Dinko Vitezic

Rijeka, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia.

Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia.

Journal: The Journal of international medical research

Published: August 08, 2026

Pharmacoeconomics of high-cost therapies: real world challenges.

Pharmacoeconomics of high-cost therapies: real world challenges.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: June 19, 2026

Nanotube-Assisted Motor Neuron and Neuromuscular Junction Stabilization in Spinal Muscular Atrophy: A Hypothesis for Adjunctive Therapy.

Nanotube-Assisted Motor Neuron and Neuromuscular Junction Stabilization in Spinal Muscular Atrophy: A Hypothesis for Adjunctive Therapy.

Journal: Neurology international

Published: March 02, 2026

Utilization Trends of SGLT2 Inhibitors in Croatian Clinical Practice: Observational Analysis.

Utilization Trends of SGLT2 Inhibitors in Croatian Clinical Practice: Observational Analysis.

Journal: Medicina (Kaunas, Lithuania)

Published: December 09, 2025

Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence.

Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence.

Journal: The Journal of international medical research

Published: November 27, 2025

Time to accelerate rare disease research: AI-powered in silico trials, digital twin-driven RCTs and decision-grade real-world evidence.

Time to accelerate rare disease research: AI-powered in silico trials, digital twin-driven RCTs and decision-grade real-world evidence.

Journal: British journal of clinical pharmacology

Published: November 06, 2025

Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacology.

Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacology.

Journal: European journal of clinical pharmacology

Published: November 06, 2025

The evolving therapeutic landscape of spinal muscular atrophy - A scoping review of investigational agents, emerging delivery technologies and strategic innovations.

The evolving therapeutic landscape of spinal muscular atrophy - A scoping review of investigational agents, emerging delivery technologies and strategic innovations.

Journal: British journal of clinical pharmacology

Published: October 21, 2025

Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy.

Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy.

Journal: Biomedicines

Published: October 21, 2025

Letter to the Editor: The Pharmacological Responsibility Chain - Mapping Competence Toward Responsible Prescribing.

Letter to the Editor: The Pharmacological Responsibility Chain - Mapping Competence Toward Responsible Prescribing.

Journal: Hospital pharmacy

Published: October 09, 2025

Letter to the editor: Expanding DPYD genotyping panels beyond current guidelines-real-world evidence and clinical-economic thoughts on inclusion of additional variants.

Letter to the editor: Expanding DPYD genotyping panels beyond current guidelines-real-world evidence and clinical-economic thoughts on inclusion of additional variants.

Journal: British journal of clinical pharmacology

Published: September 12, 2025

Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union.

Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union.

Journal: Neurology international

Published: September 02, 2025

Showing 1-12 of 58

Last Updated: 09/26/2026